Alnylam Pharmaceuticals shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $131M | 474k | 275.00 |
| 2024-06-30 | $164M | 674k | 243.00 |
| 2024-03-31 | $119M | 798k | 149.45 |
| 2023-12-31 | $160M | 837k | 191.41 |
| 2023-09-30 | $148M | 837k | 177.10 |
| 2023-06-30 | $147M | 776k | 189.94 |
| 2023-03-31 | $111M | 554k | 200.32 |
| 2022-12-31 | $137M | 574k | 237.65 |
| 2022-09-30 | $0 | 567k | 0.00 |
| 2022-06-30 | $99M | 675k | 145.88 |
| 2022-03-31 | $104M | 639k | 163.29 |
| 2021-12-31 | $0 | 602k | 0.00 |
| 2021-09-30 | $0 | 453k | 0.00 |
| 2021-06-30 | $75M | 442k | 169.52 |
| 2021-03-31 | $60M | 422k | 141.19 |
| 2020-12-31 | $58M | 443k | 129.97 |
| 2020-09-30 | $63M | 435k | 145.60 |
| 2020-06-30 | $70M | 435k | 160.00 |
| 2020-03-31 | $48M | 443k | 108.85 |
| 2019-12-31 | $51M | 442k | 115.17 |
| 2019-09-30 | $36M | 451k | 80.42 |
| 2019-06-30 | $29M | 401k | 72.56 |
| 2019-03-31 | $37M | 390k | 93.45 |
| 2018-12-31 | $36M | 496k | 72.91 |
| 2018-09-30 | $45M | 512k | 87.52 |
| 2018-06-30 | $50M | 512k | 98.49 |
| 2018-03-31 | $47M | 398k | 119.10 |
| 2017-12-31 | $50M | 395k | 127.05 |
| 2017-06-30 | $27M | 334k | 79.76 |
| 2017-03-31 | $16M | 306k | 51.25 |
| 2016-12-31 | $11M | 303k | 37.44 |
| 2016-09-30 | $22M | 327k | 67.78 |
| 2016-06-30 | $19M | 349k | 55.49 |